Healthcare & Pharmaceutical
RSS Feed

MorphoSys Announces that its Licensee Janssen has Expanded Clinical Development of Guselkumab (Tremfya(R)) into Ulcerative Colitis
1/17/2019 -- 4:25 PM -- MorphoSys AG

Innovaccer Closes $35 Million Round with Microsoft's Venture Fund, Lightspeed, and Westbridge
1/17/2019 -- 11:20 AM -- Innovaccer Inc.

Exactus Inc. Announces Entry into Hemp CBD Market
1/17/2019 -- 9:29 AM -- Exactus, Inc.

DECN Discusses Its Panacea GenUltimate! TBG System, Offering Elite Performance And Premier Upgrade Path For 4+ Million Users Of Lifescan Ultra Meters
1/17/2019 -- 8:50 AM -- Decision Diagnostics Corp.

Cormedix Inc. Announces Highly Statistically Significant Topline Results For Neutrolin(R) From The Interim Analysis Of The Phase 3 Lock-It-100 Study
1/17/2019 -- 8:00 AM -- CorMedix, Inc.

CorMedix Inc. Announces Resignation of Member of Its Board of Directors
1/16/2019 -- 4:15 PM -- CorMedix, Inc.

MDNA Life Sciences' Study Reports That Mitochondrial DNA Deletions Accurately Detect Endometriosis in Circulating Blood
1/16/2019 -- 10:20 AM -- MDNA Life Sciences Inc.

Nadia Murad, Winner of the 2018 Nobel Peace Prize, Comments on the ''Out of the Shadows Index''
1/16/2019 -- 8:00 AM -- World Childhood Foundation USA

United Cannabis Corporation Opens Colorado Hemp Testing Facility
1/15/2019 -- 2:10 PM -- United Cannabis Corporation

Aytu BioScience Announces U.S. Field Sales Launch of Tuzistra(R) XR
1/15/2019 -- 8:05 AM -- Aytu BioScience, Inc.

Weekend Unlimited Announces Acquisition of Verve Beverage Company (VBC)
1/15/2019 -- 3:05 AM -- Weekend Unlimited Inc.

UPDATE: Heat Biologics Doses First Patient in New Cohort of its Expanded Phase 2 Trial of HS-110 in Combination with Merck's KEYTRUDA(R) in Non-Small Cell Lung Cancer Trial
1/14/2019 -- 2:15 PM -- Heat Biologics, Inc.

Heat Biologics Doses First Patient in New Cohort of its Expanded Phase 2 Trial of HS-110 in Combination with Merck's KEYTRUDA(R) in Non-Small Cell Lung Cancer Trial
1/14/2019 -- 8:00 AM -- Heat Biologics, Inc.

EastWest Bioscience Opens Sangster's Health Center at Marlborough Mall in Calgary as a Corporate Store
1/14/2019 -- 8:00 AM -- EastWest BioScience Group

Weekend Unlimited President and CEO, Paul Chu to Present at Benzinga Cannabis Capital Conference
1/14/2019 -- 3:05 AM -- Weekend Unlimited Inc.

MedSource Labs Donates More than 40,000 Medical Supplies to Médecins Sans Frontières/Doctors Without Borders
1/11/2019 -- 10:13 AM -- MedSource International, Inc.

Weekend Unlimited Live Celebrates in New York City
1/11/2019 -- 3:05 AM -- Weekend Unlimited Inc.

HollyWeed North Manufacturing & Extracts Inc. (a Subsidiary of HollyWeed North Cannabis Inc.) Receives Cannabis Processing License and Launches Their First Manufacturing Line
1/10/2019 -- 5:07 PM -- HollyWeed North Cannabis Inc.

Survey Says: Millennials Realize They Have Daily Toxin Exposure; Few Know What to Do About It
1/10/2019 -- 9:25 AM -- CW Marketing & Communications

Aytu BioScience Provides Natesto(R) Commercial Update for the Quarter Ending December 31, 2018, Reports 27% Prescription Growth and Expansion of Natesto(R) Direct Program
1/10/2019 -- 8:05 AM -- Aytu BioScience, Inc.

Heat Biologics Provides Clinical and Business Update
1/10/2019 -- 7:30 AM -- Crescendo Communications, LLC

Weekend Unlimited Announces Acquisition of Canna Candys and Medibles
1/10/2019 -- 3:05 AM -- Weekend Unlimited Inc.

Najib Babul Asks Whether Fentanyl Test Strips an Effective Method to Prevent Opioid Overdose Deaths
1/9/2019 -- 3:30 PM -- Cinergen

Jaguar Health Receives First Order for First-Generation of Equilevia, the Company's Non-Prescription, Personalized, Premium Product for Total Gut Health in High-Performance Equine Athletes
1/9/2019 -- 9:00 AM -- Jaguar Health, Inc.

Preferred Dental Technologies Inc. (''Company'') (CSE: PDTI, US OTC: PDTTF): Reviews 2018 Milestones and Achievements and Plans Forward for 2019
1/9/2019 -- 8:15 AM -- Preferred Dental Technologies Inc.